NORD
Nordicus Partners Corporation Common Stock
Nasdaq · usd
Stock performance
How Nordicus Partners Corporation Common Stock (NORD) stock has performed from one day to one year, with its 52-week range.
- 1D
- -9.70%
- 1W
- -16.92%
- 1M
- -33.82%
- YTD
- -46.00%
- 1Y
- -44.90%
- 52-wk range
- $1.48 – $5.15
Key statistics
Today's trading snapshot for NORD: day range, open, previous close, volume and market cap.
- Day range
- —
- Open
- —
- Prev close
- $2.70
- Volume
- 0
- Market cap
- $52.5M
- Shares out
- 19.52M
8-K filings
Material corporate events Nordicus Partners Corporation Common Stock has disclosed to the SEC on Form 8-K.
- Debt issuanceNov 10, 2026
On November 5, 2026, Nordicus Partners Corporation issued to the Investors Convertible Grid Promissory Notes, each in the principal amount of $300,000 ($1,200,000 in total). Each Note bears interest at a rate of 5.0% per annum and matures on November 3, 2027; principal is due and payable at maturity.
- Private placementNov 4, 2026
In July and October 2026, we received subscription commitments from two private investors for a total of 40,000 restricted shares of our common stock, par value $0.001 per share. The price per share was $2.00. The proceeds to us were $80,000. On October 29, 2026, we closed the private offering and issued such shares on these terms.
Dividend history and stock splits
Nordicus Partners Corporation Common Stock's recent dividend payments and stock splits.
Dividends
- $0.18ex-div Apr 24, 2020
Splits
- 1-for-10Nov 8, 2024
NORD short interest
How heavily NORD is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 1.0
- Short interest
- 3.87K
- Avg volume
- 18.24K
As of · reported to FINRA twice monthly.
NORD news
The latest news and headlines about Nordicus Partners Corporation Common Stock (NORD).
- Nordicus Partners Corporation Corporate UpdatepositiveGlobeNewswire Inc.· Jun 15, 2026
- Orocidin and Syngene Partner to Accelerate Biotech InnovationpositiveGlobeNewswire Inc.· Feb 20, 2025
- Nordicus Partners Corporation Announces Key Milestone in Development of Orocidin’s Breakthrough Treatment for PeriodontitispositiveGlobeNewswire Inc.· Jan 14, 2025
- Nordicus Partners Corporation Enters Into A Consultancy Agreement With BIO-CONVERT In DenmarkGlobeNewswire Inc.· Jun 21, 2024
- Orocidin – New Insights Into The Treatment Of PeriodontitisGlobeNewswire Inc.· Jun 11, 2024
Frequently asked questions
What is the Nordicus Partners Corporation Common Stock (NORD) stock price today?
Massive provides real-time and historical Nordicus Partners Corporation Common Stock (NORD) quotes via REST API, WebSocket and MCP.
What is Nordicus Partners Corporation Common Stock?
Nordicus Partners Corp specializes in developing breakthrough therapeutics for diseases with unmet medical needs. The Company focuses on acquiring and developing drugs from biotech companies in the Nordics, a region known for its scientists, life sciences ecosystem, and drug…
What is the short interest in NORD?
As of Oct 15, 2026, NORD has 3.87K shares short and 1.0 days to cover.
Does Nordicus Partners Corporation Common Stock (NORD) pay a dividend?
Yes. Nordicus Partners Corporation Common Stock (NORD)'s most recent dividend was $0.18 per share, with an ex-dividend date of Apr 24, 2020. Full NORD dividend history is available from the Massive API.
What exchange is NORD listed on?
Nordicus Partners Corporation Common Stock (NORD) trades on Nasdaq in USD, in the SERVICES-MANAGEMENT CONSULTING SERVICES industry.
Build with AI
Build an analysis of NORD with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a NORD analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.